0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Medical Inhaled Nitric Oxide Market Research Report 2026
Published Date: 2026-04-16
|
Report Code: QYRE-Auto-14W9053
Home | Market Reports | Health| Medical Devices & Equipment
Global Medical Inhaled Nitric Oxide Market Outlook 2022
BUY CHAPTERS

Global Medical Inhaled Nitric Oxide Market Research Report 2026

Code: QYRE-Auto-14W9053
Report
2026-04-16
Pages:102
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Medical Inhaled Nitric Oxide Market Size

The global Medical Inhaled Nitric Oxide market was valued at US$ 659 million in 2025 and is anticipated to reach US$ 985 million by 2032, at a CAGR of 6.0% from 2026 to 2032.

Medical Inhaled Nitric Oxide Market

Medical Inhaled Nitric Oxide Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Medical Inhaled Nitric Oxide competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Inhaled Nitric Oxide (iNO) therapy is a medical treatment involving the inhalation of nitric oxide gas, primarily used to treat conditions such as Acute Respiratory Distress Syndrome (ARDS), pulmonary hypertension, and neonatal pulmonary hypertension. As a gas-based therapy, iNO works by relaxing the smooth muscles of the pulmonary blood vessels, reducing pulmonary vascular resistance, and thereby improving oxygenation and reducing the load on the lungs and heart. iNO is most commonly used in intensive care units (ICUs), particularly for critically ill neonates and adults. Compared to traditional pharmacological treatments, iNO offers a more precise way to regulate blood flow and oxygen supply to the lungs, with fewer side effects. The therapy is delivered through specialized devices, such as inhaled nitric oxide therapy systems, portable inhalation devices, and other apparatus designed to deliver controlled amounts of nitric oxide directly to patients. These devices typically include real-time monitoring of nitric oxide concentration, oxygen levels, and gas flow rates, ensuring precise and safe treatment.
The product range for medical inhaled nitric oxide includes large ICU systems, portable systems, and home-care systems. With advancements in technology, there is an increasing demand for more efficient and user-friendly devices, especially in home-care settings. Portable nitric oxide therapy systems have become particularly important for neonates and adults with chronic conditions, offering both acute and long-term therapeutic benefits. As such, iNO therapy plays an essential role not only in emergency care but also in ongoing treatment for patients with complex respiratory issues.
The medical inhaled nitric oxide (iNO) market is experiencing rapid growth, driven by multiple factors. First, the rising incidence of chronic respiratory diseases and Acute Respiratory Distress Syndrome (ARDS) has significantly increased the demand for iNO therapy. With the aging global population and the high prevalence of lung and cardiovascular diseases, iNO has become an essential treatment option. Particularly in neonatal intensive care, iNO is widely used to treat conditions such as neonatal pulmonary hypertension. Second, with advancements in medical technology, iNO devices are becoming more compact and portable, increasing the accessibility of iNO therapy outside of hospital settings. This shift has opened up vast opportunities for home care and telemedicine solutions, expanding the market.
However, there are risks and challenges in the market. First, the high cost of iNO therapy equipment presents a significant barrier, particularly for healthcare institutions in developing countries. Second, the use of iNO requires specialized equipment and expertise, leading to a need for extensive training for healthcare providers. Furthermore, prolonged use of iNO may lead to potential side effects, such as damage to the lungs or other organs due to high concentrations of nitrogen oxides, necessitating strict monitoring during therapy. The market is also highly concentrated, with a few major players dominating, which could potentially lead to market imbalances in terms of competition.
With ongoing advancements in technology, the performance and reliability of iNO devices continue to improve. Emerging technological trends include more precise gas delivery systems, integrated smart monitoring features, and the development of user-friendly home therapy systems. In the future, the integration of artificial intelligence and big data into iNO therapy could lead to more personalized and intelligent treatment solutions, marking a new direction in the market's evolution.
This report delivers a comprehensive overview of the global Medical Inhaled Nitric Oxide market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Medical Inhaled Nitric Oxide. The Medical Inhaled Nitric Oxide market size, estimates, and forecasts are provided in terms of sales volume (Million L) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Medical Inhaled Nitric Oxide market comprehensively. Regional market sizes by NO Concentration, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Medical Inhaled Nitric Oxide manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by NO Concentration, by Application, and by region.
Market Segmentation

Scope of Medical Inhaled Nitric Oxide Market Report

Report Metric Details
Report Name Medical Inhaled Nitric Oxide Market
Accounted market size in 2025 US$ 659 million
Forecasted market size in 2032 US$ 985 million
CAGR 6.0%
Base Year 2025
Forecasted years 2026 - 2032
Segment by NO Concentration
  • High Purity iNO
  • Standard Purity iNO
by Application
  • Infants PPHN
  • ARDS, etc.
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Mallinckrodt (INOmax), Linde (Noxivent), Air Liquide (KINOX)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by NO Concentration, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Medical Inhaled Nitric Oxide manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Medical Inhaled Nitric Oxide sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by NO Concentration, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Medical Inhaled Nitric Oxide Market growing?

Ans: The Medical Inhaled Nitric Oxide Market witnessing a CAGR of 6.0% during the forecast period 2026-2032.

What is the Medical Inhaled Nitric Oxide Market size in 2032?

Ans: The Medical Inhaled Nitric Oxide Market size in 2032 will be US$ 985 million.

Who are the main players in the Medical Inhaled Nitric Oxide Market report?

Ans: The main players in the Medical Inhaled Nitric Oxide Market are Mallinckrodt (INOmax), Linde (Noxivent), Air Liquide (KINOX)

What are the Application segmentation covered in the Medical Inhaled Nitric Oxide Market report?

Ans: The Applications covered in the Medical Inhaled Nitric Oxide Market report are Infants PPHN, ARDS, etc.

1 Medical Inhaled Nitric Oxide Market Overview
1.1 Product Definition
1.2 Medical Inhaled Nitric Oxide by NO Concentration
1.2.1 Global Medical Inhaled Nitric Oxide Market Value by NO Concentration: 2025 vs 2032
1.2.2 High Purity iNO
1.2.3 Standard Purity iNO
1.3 Medical Inhaled Nitric Oxide by Application
1.3.1 Global Medical Inhaled Nitric Oxide Market Value by Application: 2025 vs 2032
1.3.2 Infants PPHN
1.3.3 ARDS, etc.
1.4 Global Medical Inhaled Nitric Oxide Market Size Estimates and Forecasts
1.4.1 Global Medical Inhaled Nitric Oxide Revenue 2021–2032
1.4.2 Global Medical Inhaled Nitric Oxide Sales 2021–2032
1.4.3 Global Medical Inhaled Nitric Oxide Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Medical Inhaled Nitric Oxide Market Competition by Manufacturers
2.1 Global Medical Inhaled Nitric Oxide Sales Market Share by Manufacturers (2021–2026)
2.2 Global Medical Inhaled Nitric Oxide Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Medical Inhaled Nitric Oxide Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Medical Inhaled Nitric Oxide, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Medical Inhaled Nitric Oxide, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Medical Inhaled Nitric Oxide, Product Types and Applications
2.7 Global Key Manufacturers of Medical Inhaled Nitric Oxide, Date of Entry into the Industry
2.8 Global Medical Inhaled Nitric Oxide Market Competitive Situation and Trends
2.8.1 Global Medical Inhaled Nitric Oxide Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Medical Inhaled Nitric Oxide Players Market Share by Revenue
2.8.3 Global Medical Inhaled Nitric Oxide Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Medical Inhaled Nitric Oxide Market Scenario by Region
3.1 Global Medical Inhaled Nitric Oxide Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Medical Inhaled Nitric Oxide Sales by Region: 2021–2032
3.2.1 Global Medical Inhaled Nitric Oxide Sales by Region: 2021–2026
3.2.2 Global Medical Inhaled Nitric Oxide Sales by Region: 2027–2032
3.3 Global Medical Inhaled Nitric Oxide Revenue by Region: 2021–2032
3.3.1 Global Medical Inhaled Nitric Oxide Revenue by Region: 2021–2026
3.3.2 Global Medical Inhaled Nitric Oxide Revenue by Region: 2027–2032
3.4 North America Medical Inhaled Nitric Oxide Market Facts & Figures by Country
3.4.1 North America Medical Inhaled Nitric Oxide Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Medical Inhaled Nitric Oxide Sales by Country (2021–2032)
3.4.3 North America Medical Inhaled Nitric Oxide Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Medical Inhaled Nitric Oxide Market Facts & Figures by Country
3.5.1 Europe Medical Inhaled Nitric Oxide Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Medical Inhaled Nitric Oxide Sales by Country (2021–2032)
3.5.3 Europe Medical Inhaled Nitric Oxide Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medical Inhaled Nitric Oxide Market Facts & Figures by Region
3.6.1 Asia Pacific Medical Inhaled Nitric Oxide Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Medical Inhaled Nitric Oxide Sales by Region (2021–2032)
3.6.3 Asia Pacific Medical Inhaled Nitric Oxide Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Medical Inhaled Nitric Oxide Market Facts & Figures by Country
3.7.1 Latin America Medical Inhaled Nitric Oxide Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Medical Inhaled Nitric Oxide Sales by Country (2021–2032)
3.7.3 Latin America Medical Inhaled Nitric Oxide Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Medical Inhaled Nitric Oxide Market Facts & Figures by Country
3.8.1 Middle East and Africa Medical Inhaled Nitric Oxide Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Medical Inhaled Nitric Oxide Sales by Country (2021–2032)
3.8.3 Middle East and Africa Medical Inhaled Nitric Oxide Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by NO Concentration
4.1 Global Medical Inhaled Nitric Oxide Sales by NO Concentration (2021–2032)
4.1.1 Global Medical Inhaled Nitric Oxide Sales by NO Concentration (2021–2026)
4.1.2 Global Medical Inhaled Nitric Oxide Sales by NO Concentration (2027–2032)
4.1.3 Global Medical Inhaled Nitric Oxide Sales Market Share by NO Concentration (2021–2032)
4.2 Global Medical Inhaled Nitric Oxide Revenue by NO Concentration (2021–2032)
4.2.1 Global Medical Inhaled Nitric Oxide Revenue by NO Concentration (2021–2026)
4.2.2 Global Medical Inhaled Nitric Oxide Revenue by NO Concentration (2027–2032)
4.2.3 Global Medical Inhaled Nitric Oxide Revenue Market Share by NO Concentration (2021–2032)
4.3 Global Medical Inhaled Nitric Oxide Price by NO Concentration (2021–2032)
5 Segment by Application
5.1 Global Medical Inhaled Nitric Oxide Sales by Application (2021–2032)
5.1.1 Global Medical Inhaled Nitric Oxide Sales by Application (2021–2026)
5.1.2 Global Medical Inhaled Nitric Oxide Sales by Application (2027–2032)
5.1.3 Global Medical Inhaled Nitric Oxide Sales Market Share by Application (2021–2032)
5.2 Global Medical Inhaled Nitric Oxide Revenue by Application (2021–2032)
5.2.1 Global Medical Inhaled Nitric Oxide Revenue by Application (2021–2026)
5.2.2 Global Medical Inhaled Nitric Oxide Revenue by Application (2027–2032)
5.2.3 Global Medical Inhaled Nitric Oxide Revenue Market Share by Application (2021–2032)
5.3 Global Medical Inhaled Nitric Oxide Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Mallinckrodt (INOmax)
6.1.1 Mallinckrodt (INOmax) Company Information
6.1.2 Mallinckrodt (INOmax) Description and Business Overview
6.1.3 Mallinckrodt (INOmax) Medical Inhaled Nitric Oxide Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Mallinckrodt (INOmax) Medical Inhaled Nitric Oxide Product Portfolio
6.1.5 Mallinckrodt (INOmax) Recent Developments/Updates
6.2 Linde (Noxivent)
6.2.1 Linde (Noxivent) Company Information
6.2.2 Linde (Noxivent) Description and Business Overview
6.2.3 Linde (Noxivent) Medical Inhaled Nitric Oxide Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Linde (Noxivent) Medical Inhaled Nitric Oxide Product Portfolio
6.2.5 Linde (Noxivent) Recent Developments/Updates
6.3 Air Liquide (KINOX)
6.3.1 Air Liquide (KINOX) Company Information
6.3.2 Air Liquide (KINOX) Description and Business Overview
6.3.3 Air Liquide (KINOX) Medical Inhaled Nitric Oxide Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Air Liquide (KINOX) Medical Inhaled Nitric Oxide Product Portfolio
6.3.5 Air Liquide (KINOX) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medical Inhaled Nitric Oxide Industry Chain Analysis
7.2 Medical Inhaled Nitric Oxide Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medical Inhaled Nitric Oxide Production Mode & Process Analysis
7.4 Medical Inhaled Nitric Oxide Sales and Marketing
7.4.1 Medical Inhaled Nitric Oxide Sales Channels
7.4.2 Medical Inhaled Nitric Oxide Distributors
7.5 Medical Inhaled Nitric Oxide Customer Analysis
8 Medical Inhaled Nitric Oxide Market Dynamics
8.1 Medical Inhaled Nitric Oxide Industry Trends
8.2 Medical Inhaled Nitric Oxide Market Drivers
8.3 Medical Inhaled Nitric Oxide Market Challenges
8.4 Medical Inhaled Nitric Oxide Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Medical Inhaled Nitric Oxide Market Value by NO Concentration (US$ Million), 2025 vs 2032
 Table 2. Global Medical Inhaled Nitric Oxide Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Medical Inhaled Nitric Oxide Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Medical Inhaled Nitric Oxide Sales (Million L) of Key Manufacturers (2021–2026)
 Table 5. Global Medical Inhaled Nitric Oxide Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Medical Inhaled Nitric Oxide Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Medical Inhaled Nitric Oxide Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Medical Inhaled Nitric Oxide Average Price (USD/L) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Medical Inhaled Nitric Oxide, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Medical Inhaled Nitric Oxide, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Medical Inhaled Nitric Oxide, Product Types and Applications
 Table 12. Global Key Manufacturers of Medical Inhaled Nitric Oxide, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Medical Inhaled Nitric Oxide Companies by Tier (Tier 1, Tier 2, Tier 3), based on Medical Inhaled Nitric Oxide Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Medical Inhaled Nitric Oxide Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Medical Inhaled Nitric Oxide Sales by Region (Million L), 2021–2026
 Table 18. Global Medical Inhaled Nitric Oxide Sales Market Share by Region (2021–2026)
 Table 19. Global Medical Inhaled Nitric Oxide Sales by Region (Million L), 2027–2032
 Table 20. Global Medical Inhaled Nitric Oxide Sales Market Share by Region (2027–2032)
 Table 21. Global Medical Inhaled Nitric Oxide Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Medical Inhaled Nitric Oxide Revenue Market Share by Region (2021–2026)
 Table 23. Global Medical Inhaled Nitric Oxide Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Medical Inhaled Nitric Oxide Revenue Market Share by Region (2027–2032)
 Table 25. North America Medical Inhaled Nitric Oxide Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Medical Inhaled Nitric Oxide Sales by Country (Million L), 2021–2026
 Table 27. North America Medical Inhaled Nitric Oxide Sales by Country (Million L), 2027–2032
 Table 28. North America Medical Inhaled Nitric Oxide Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Medical Inhaled Nitric Oxide Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Medical Inhaled Nitric Oxide Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Medical Inhaled Nitric Oxide Sales by Country (Million L), 2021–2026
 Table 32. Europe Medical Inhaled Nitric Oxide Sales by Country (Million L), 2027–2032
 Table 33. Europe Medical Inhaled Nitric Oxide Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Medical Inhaled Nitric Oxide Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Medical Inhaled Nitric Oxide Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Medical Inhaled Nitric Oxide Sales by Region (Million L), 2021–2026
 Table 37. Asia Pacific Medical Inhaled Nitric Oxide Sales by Region (Million L), 2027–2032
 Table 38. Asia Pacific Medical Inhaled Nitric Oxide Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Medical Inhaled Nitric Oxide Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Medical Inhaled Nitric Oxide Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Medical Inhaled Nitric Oxide Sales by Country (Million L), 2021–2026
 Table 42. Latin America Medical Inhaled Nitric Oxide Sales by Country (Million L), 2027–2032
 Table 43. Latin America Medical Inhaled Nitric Oxide Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Medical Inhaled Nitric Oxide Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Medical Inhaled Nitric Oxide Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Medical Inhaled Nitric Oxide Sales by Country (Million L), 2021–2026
 Table 47. Middle East and Africa Medical Inhaled Nitric Oxide Sales by Country (Million L), 2027–2032
 Table 48. Middle East and Africa Medical Inhaled Nitric Oxide Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Medical Inhaled Nitric Oxide Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Medical Inhaled Nitric Oxide Sales (Million L) by NO Concentration (2021–2026)
 Table 51. Global Medical Inhaled Nitric Oxide Sales (Million L) by NO Concentration (2027–2032)
 Table 52. Global Medical Inhaled Nitric Oxide Sales Market Share by NO Concentration (2021–2026)
 Table 53. Global Medical Inhaled Nitric Oxide Sales Market Share by NO Concentration (2027–2032)
 Table 54. Global Medical Inhaled Nitric Oxide Revenue (US$ Million) by NO Concentration (2021–2026)
 Table 55. Global Medical Inhaled Nitric Oxide Revenue (US$ Million) by NO Concentration (2027–2032)
 Table 56. Global Medical Inhaled Nitric Oxide Revenue Market Share by NO Concentration (2021–2026)
 Table 57. Global Medical Inhaled Nitric Oxide Revenue Market Share by NO Concentration (2027–2032)
 Table 58. Global Medical Inhaled Nitric Oxide Price (USD/L) by NO Concentration (2021–2026)
 Table 59. Global Medical Inhaled Nitric Oxide Price (USD/L) by NO Concentration (2027–2032)
 Table 60. Global Medical Inhaled Nitric Oxide Sales (Million L) by Application (2021–2026)
 Table 61. Global Medical Inhaled Nitric Oxide Sales (Million L) by Application (2027–2032)
 Table 62. Global Medical Inhaled Nitric Oxide Sales Market Share by Application (2021–2026)
 Table 63. Global Medical Inhaled Nitric Oxide Sales Market Share by Application (2027–2032)
 Table 64. Global Medical Inhaled Nitric Oxide Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Medical Inhaled Nitric Oxide Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Medical Inhaled Nitric Oxide Revenue Market Share by Application (2021–2026)
 Table 67. Global Medical Inhaled Nitric Oxide Revenue Market Share by Application (2027–2032)
 Table 68. Global Medical Inhaled Nitric Oxide Price (USD/L) by Application (2021–2026)
 Table 69. Global Medical Inhaled Nitric Oxide Price (USD/L) by Application (2027–2032)
 Table 70. Mallinckrodt (INOmax) Company Information
 Table 71. Mallinckrodt (INOmax) Description and Business Overview
 Table 72. Mallinckrodt (INOmax) Medical Inhaled Nitric Oxide Sales (Million L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)
 Table 73. Mallinckrodt (INOmax) Medical Inhaled Nitric Oxide Product
 Table 74. Mallinckrodt (INOmax) Recent Developments/Updates
 Table 75. Linde (Noxivent) Company Information
 Table 76. Linde (Noxivent) Description and Business Overview
 Table 77. Linde (Noxivent) Medical Inhaled Nitric Oxide Sales (Million L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)
 Table 78. Linde (Noxivent) Medical Inhaled Nitric Oxide Product
 Table 79. Linde (Noxivent) Recent Developments/Updates
 Table 80. Air Liquide (KINOX) Company Information
 Table 81. Air Liquide (KINOX) Description and Business Overview
 Table 82. Air Liquide (KINOX) Medical Inhaled Nitric Oxide Sales (Million L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)
 Table 83. Air Liquide (KINOX) Medical Inhaled Nitric Oxide Product
 Table 84. Air Liquide (KINOX) Recent Developments/Updates
 Table 85. Key Raw Materials Lists
 Table 86. Raw Materials Key Suppliers Lists
 Table 87. Medical Inhaled Nitric Oxide Distributors List
 Table 88. Medical Inhaled Nitric Oxide Customers List
 Table 89. Medical Inhaled Nitric Oxide Market Trends
 Table 90. Medical Inhaled Nitric Oxide Market Drivers
 Table 91. Medical Inhaled Nitric Oxide Market Challenges
 Table 92. Medical Inhaled Nitric Oxide Market Restraints
 Table 93. Research Programs/Design for This Report
 Table 94. Key Data Information from Secondary Sources
 Table 95. Key Data Information from Primary Sources
 Table 96. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Medical Inhaled Nitric Oxide
 Figure 2. Global Medical Inhaled Nitric Oxide Market Value by NO Concentration (US$ Million), 2021–2032
 Figure 3. Global Medical Inhaled Nitric Oxide Market Share by NO Concentration: 2025 & 2032
 Figure 4. High Purity iNO Product Picture
 Figure 5. Standard Purity iNO Product Picture
 Figure 6. Global Medical Inhaled Nitric Oxide Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Medical Inhaled Nitric Oxide Market Share by Application: 2025 & 2032
 Figure 8. Infants PPHN
 Figure 9. ARDS, etc.
 Figure 10. Global Medical Inhaled Nitric Oxide Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 11. Global Medical Inhaled Nitric Oxide Market Size (US$ Million), 2021–2032
 Figure 12. Global Medical Inhaled Nitric Oxide Sales (Million L), 2021–2032
 Figure 13. Global Medical Inhaled Nitric Oxide Average Price (USD/L), 2021–2032
 Figure 14. Medical Inhaled Nitric Oxide Report Years Considered
 Figure 15. Medical Inhaled Nitric Oxide Sales Share by Manufacturers in 2025
 Figure 16. Global Medical Inhaled Nitric Oxide Revenue Share by Manufacturers in 2025
 Figure 17. Top 5 and Top 10 Global Medical Inhaled Nitric Oxide Players: Market Share by Revenue in Medical Inhaled Nitric Oxide in 2025
 Figure 18. Medical Inhaled Nitric Oxide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 19. Global Medical Inhaled Nitric Oxide Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 20. North America Medical Inhaled Nitric Oxide Sales Market Share by Country (2021–2032)
 Figure 21. North America Medical Inhaled Nitric Oxide Revenue Market Share by Country (2021–2032)
 Figure 22. United States Medical Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 23. Canada Medical Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Europe Medical Inhaled Nitric Oxide Sales Market Share by Country (2021–2032)
 Figure 25. Europe Medical Inhaled Nitric Oxide Revenue Market Share by Country (2021–2032)
 Figure 26. Germany Medical Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. France Medical Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. U.K. Medical Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Italy Medical Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Russia Medical Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Asia Pacific Medical Inhaled Nitric Oxide Sales Market Share by Region (2021–2032)
 Figure 32. Asia Pacific Medical Inhaled Nitric Oxide Revenue Market Share by Region (2021–2032)
 Figure 33. China Medical Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Japan Medical Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. South Korea Medical Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. India Medical Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Australia Medical Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. China Taiwan Medical Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Indonesia Medical Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Thailand Medical Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Malaysia Medical Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Latin America Medical Inhaled Nitric Oxide Sales Market Share by Country (2021–2032)
 Figure 43. Latin America Medical Inhaled Nitric Oxide Revenue Market Share by Country (2021–2032)
 Figure 44. Mexico Medical Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Brazil Medical Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Argentina Medical Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Middle East and Africa Medical Inhaled Nitric Oxide Sales Market Share by Country (2021–2032)
 Figure 48. Middle East and Africa Medical Inhaled Nitric Oxide Revenue Market Share by Country (2021–2032)
 Figure 49. Turkey Medical Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Saudi Arabia Medical Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. UAE Medical Inhaled Nitric Oxide Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Global Sales Market Share of Medical Inhaled Nitric Oxide by NO Concentration (2021–2032)
 Figure 53. Global Revenue Market Share of Medical Inhaled Nitric Oxide by NO Concentration (2021–2032)
 Figure 54. Global Medical Inhaled Nitric Oxide Price (USD/L) by NO Concentration (2021–2032)
 Figure 55. Global Sales Market Share of Medical Inhaled Nitric Oxide by Application (2021–2032)
 Figure 56. Global Revenue Market Share of Medical Inhaled Nitric Oxide by Application (2021–2032)
 Figure 57. Global Medical Inhaled Nitric Oxide Price (USD/L) by Application (2021–2032)
 Figure 58. Medical Inhaled Nitric Oxide Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS